1-24 of 69 Books
"Man-in-the-plant" revisited, a deceptive drug labeling practice continues
"Man-in-the-plant" revisited, a deceptive drug labeling practice continues
By United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations.
Greater access to generic drugs
Greater access to generic drugs
By Michelle Meadows
FDA ensures equivalence of generic drugs
FDA ensures equivalence of generic drugs
By Jeffrey Yorke
Increasing generic drug utilization
Increasing generic drug utilization
By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

Generic drug entry prior to patent expiration
By United States. Federal Trade Commission.

Drug comparison handbook
By Reilly, Robert Pharm.D.
Generic substitution and prescription drug prices
Generic substitution and prescription drug prices
By Alison Masson

Competition in the pharmaceutical industry
By Meir Statman
Generic drug substitution
Generic drug substitution
By Calvin Azama
Two aspects of drug pricing
Two aspects of drug pricing
By Wisconsin. Legislature. Legislative Reference Bureau.
Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace
Legislative and regulatory responses to the FTC study on barriers to entry in the pharmaceutical marketplace
By United States. Congress. Senate. Committee on the Judiciary
Penalties for illegal activities in the approval of drugs
Penalties for illegal activities in the approval of drugs
By United States. Congress. House. Committee on Energy and Conmmerce. Subcommittee on Health and the Environment.
The market for prescription generic drugs (A Kalorama Information market intelligence report)
The market for prescription generic drugs (A Kalorama Information market intelligence report)
By Mary Anne Crandall
Public hearing before Assembly Commerce, Industry and Professions Committee : on Assembly bill no. 1257 (generic drug substitution), held June 3 [and June 28] 1974 ...
Public hearing before Assembly Commerce, Industry and Professions Committee : on Assembly bill no. 1257 (generic drug substitution), held June 3 [and June 28] 1974 ...
By New Jersey. Legislature. General Assembly. Committee on Commerce, Industry, and Professions.
Illinois formulary
Illinois formulary
By Illinois. Division of Food and Drugs.

Drug pricing
By United States. Congress. Senate. Committee on Governmental Affairs.

Pharmaceutical patent issues
By United States. Congress. Senate. Committee on the Judiciary
The Market for RX-To-OTC Switches (Kalorama Information Market Intelligence Report)
The Market for RX-To-OTC Switches (Kalorama Information Market Intelligence Report)
By Melissa Elder